☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
global rights
AstraZeneca to Divest Global Rights of Movantik (naloxegol) to RedHill Biopharma
February 25, 2020
With Continuous Failure Active Biotech Regains Global Rights for Laquinimod from Teva
September 6, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
